RxDoctor Payments Data

Amber Mayfield, PA

Medical · Fayetteville, GANPI 1891860094

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.4% of the total across 527 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 23.5% — the pattern of someone who eats at a lot of different presentations. Among medical clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$10,015in general payments, 2019–2025

Across 527 payments — averaging $19.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • UCB, Inc.$1K
  • Novartis$959
  • Johnson & Johnson$803
  • Regeneron Healthcare Solutions, Inc.$779
  • Sanofi$701
  • plus $3K from 20 others

What the payments were for

  • Food & beverage$9,75197%
  • Education$2643%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$10,015 in reported general payments places this provider in the 90th percentile of 950 medical providers in Georgia.

See all medical providers in Georgia

Medicare billing

Part B allowed, 2024
$237,263
Medicare patients
642
Services billed
4,397

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab115$423,874
Skyrizi PenRisankizumab-Rzaa15$299,163
Cosentyx Sensoready (2 Pens)Secukinumab33$266,191
Humira(Cf) PenAdalimumab25$240,039
Clobetasol Propionate73$2,408
Fluorouracil37$2,384
Doxycycline Hyclate59$2,374
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc51$1,574
Doxepin Hcl22$1,048
Metronidazole18$1,019
Triamcinolone Acetonide96$991
Ketoconazole64$899
Fluocinonide26$831
Mupirocin117$817
Betamethasone Dipropionate14$775

Paid to pharmacies, not to this prescriber.

Other medical in Fayetteville

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →